Suchergebnisse

The Federal Reserve kept interest rates unchanged at 3.5%–3.75% following its two-day policy meeting on Wednesday, in line with market expectations. Alongside the decision, policymakers released

For Immediate Release

Chicago, IL – March 19, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Avanos Medical, Inc. AVNS is well-poised for growth in the coming quarters, courtesy of its impressive product line. The optimism, led by a decent fourth-quarter fiscal 2025 performance and

Darden Restaurants, Inc. DRI reported third-quarter fiscal 2026 results, with earnings meeting the Zacks Consensus Estimate and revenues beating the same. The top and bottom lines increased on a

Shares of Xenon Pharmaceuticals (XENE) have gained approximately 20% over the past three months, primarily driven by positive top-line data from the X-TOLE2 study evaluating its lead candidate

Intuitive Machines, Inc. (LUNR) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.04 per share a year ago. These figures

Ocugen OCGN is entering a period where the stock can be driven more by calendar-based catalysts than traditional fundamentals. Multiple late-stage readouts and filing steps are lined up across its

Lands’ End, Inc. LE reported fourth-quarter fiscal 2025 results, with the top and bottom lines missing the Zacks Consensus Estimate. However, both metrics showed year-over-year growth.

LE’s

Pfizer PFE reported positive top-line results from a late-stage study evaluating Talzenna (talazoparib), an oral PARP inhibitor, in combination with Xtandi (enzalutamide), an ARP inhibitor. The

Robinhood Markets, Inc. HOOD is taking a step toward becoming a hub for active traders by launching the beta version of its in-app community feature, Robinhood Social. Introduced at the HOOD Summit

SailPoint SAIL reported fourth-quarter fiscal 2026 earnings of 8 cents per share, in line with the Zacks Consensus Estimate. The company reported a loss of $4.29 in the year-ago quarter.Revenues

Eli Lilly LLY announced positive top-line results from a late-stage study evaluating its experimental once-weekly weight-loss drug, retatrutide, in adults with type II diabetes (T2D)

This study

Delta Air Lines DAL is expanding its footprint in Central Texas by introducing new routes and boosting seasonal connectivity from Austin-Bergstrom International Airport. The airline will launch

ZTO Express ZTO is bolstered by a robust demand scenario, boosting the company’s top-line. The shareholder-friendly initiatives are encouraging. With these tailwinds, ZTO’s shares have performed

Shares of Insmed INSM gained nearly 6% on Monday after the company reported positive top-line results from the phase IIIb ENCORE study evaluating Arikayce for label expansion in mycobacterium avium

The intensifying war in the Middle East between Iran and the U.S.-Israel joint force has moved beyond a regional conflict, choking global energy supply lines. In a latest development, this conflict

Shares of Valneva VALN tanked 37% on Monday after the company reported top-line results from the phase III VALOR study, which evaluated its experimental Lyme disease vaccine, PF-07307405 (formerly

Chewy, Inc. CHWY is likely to report top-line growth when it reports fourth-quarter fiscal 2025 results tomorrow. The Zacks Consensus Estimate for quarterly sales is currently pegged at $3.3